THERAPEUTIC AGENT FOR AMNIOTIC FLUID EMBOLISM
The present invention relates to a therapeutic agent for amniotic fluid embolism (AFE). Furthermore, the present invention relates to a therapeutic agent for AFE comprising a C1 -inhibitor, particularly a human plasma-derived C1 -inhibitor. La présente invention concerne un agent thérapeutique pour...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | IKEDA, TOMOAKI FURUHASHI, MADOKA KANAYAMA, NAOHIRO |
description | The present invention relates to a therapeutic agent for amniotic fluid embolism (AFE). Furthermore, the present invention relates to a therapeutic agent for AFE comprising a C1 -inhibitor, particularly a human plasma-derived C1 -inhibitor.
La présente invention concerne un agent thérapeutique pour l'embolie de liquide amniotique (ELA). La présente invention concerne également un agent thérapeutique pour l'ELA qui comprend un inhibiteur de la C1, en particulier un inhibiteur de la C1 dérivé du plasma humain. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2014131865A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2014131865A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2014131865A13</originalsourceid><addsrcrecordid>eNrjZNAN8XANcgxwDQ3xdFZwdHf1C1Fw8w9ScPT18_QHCbn5hHq6KLj6Ovn7eAb78jCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-HB_IwNDE0NjQwszU0dDY-JUAQBPvCZW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THERAPEUTIC AGENT FOR AMNIOTIC FLUID EMBOLISM</title><source>esp@cenet</source><creator>IKEDA, TOMOAKI ; FURUHASHI, MADOKA ; KANAYAMA, NAOHIRO</creator><creatorcontrib>IKEDA, TOMOAKI ; FURUHASHI, MADOKA ; KANAYAMA, NAOHIRO</creatorcontrib><description>The present invention relates to a therapeutic agent for amniotic fluid embolism (AFE). Furthermore, the present invention relates to a therapeutic agent for AFE comprising a C1 -inhibitor, particularly a human plasma-derived C1 -inhibitor.
La présente invention concerne un agent thérapeutique pour l'embolie de liquide amniotique (ELA). La présente invention concerne également un agent thérapeutique pour l'ELA qui comprend un inhibiteur de la C1, en particulier un inhibiteur de la C1 dérivé du plasma humain.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140904&DB=EPODOC&CC=WO&NR=2014131865A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140904&DB=EPODOC&CC=WO&NR=2014131865A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IKEDA, TOMOAKI</creatorcontrib><creatorcontrib>FURUHASHI, MADOKA</creatorcontrib><creatorcontrib>KANAYAMA, NAOHIRO</creatorcontrib><title>THERAPEUTIC AGENT FOR AMNIOTIC FLUID EMBOLISM</title><description>The present invention relates to a therapeutic agent for amniotic fluid embolism (AFE). Furthermore, the present invention relates to a therapeutic agent for AFE comprising a C1 -inhibitor, particularly a human plasma-derived C1 -inhibitor.
La présente invention concerne un agent thérapeutique pour l'embolie de liquide amniotique (ELA). La présente invention concerne également un agent thérapeutique pour l'ELA qui comprend un inhibiteur de la C1, en particulier un inhibiteur de la C1 dérivé du plasma humain.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAN8XANcgxwDQ3xdFZwdHf1C1Fw8w9ScPT18_QHCbn5hHq6KLj6Ovn7eAb78jCwpiXmFKfyQmluBmU31xBnD93Ugvz41OKCxOTUvNSS-HB_IwNDE0NjQwszU0dDY-JUAQBPvCZW</recordid><startdate>20140904</startdate><enddate>20140904</enddate><creator>IKEDA, TOMOAKI</creator><creator>FURUHASHI, MADOKA</creator><creator>KANAYAMA, NAOHIRO</creator><scope>EVB</scope></search><sort><creationdate>20140904</creationdate><title>THERAPEUTIC AGENT FOR AMNIOTIC FLUID EMBOLISM</title><author>IKEDA, TOMOAKI ; FURUHASHI, MADOKA ; KANAYAMA, NAOHIRO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2014131865A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2014</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>IKEDA, TOMOAKI</creatorcontrib><creatorcontrib>FURUHASHI, MADOKA</creatorcontrib><creatorcontrib>KANAYAMA, NAOHIRO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IKEDA, TOMOAKI</au><au>FURUHASHI, MADOKA</au><au>KANAYAMA, NAOHIRO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THERAPEUTIC AGENT FOR AMNIOTIC FLUID EMBOLISM</title><date>2014-09-04</date><risdate>2014</risdate><abstract>The present invention relates to a therapeutic agent for amniotic fluid embolism (AFE). Furthermore, the present invention relates to a therapeutic agent for AFE comprising a C1 -inhibitor, particularly a human plasma-derived C1 -inhibitor.
La présente invention concerne un agent thérapeutique pour l'embolie de liquide amniotique (ELA). La présente invention concerne également un agent thérapeutique pour l'ELA qui comprend un inhibiteur de la C1, en particulier un inhibiteur de la C1 dérivé du plasma humain.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2014131865A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | THERAPEUTIC AGENT FOR AMNIOTIC FLUID EMBOLISM |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T08%3A18%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IKEDA,%20TOMOAKI&rft.date=2014-09-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2014131865A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |